Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruno, C.
Right arrow Articles by Minetti, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruno, C.
Right arrow Articles by Minetti, C.
NEUROLOGY 2004;62:13-16
© 2004 American Academy of Neurology
Views & Reviews

Clinical and molecular findings in patients with giant axonal neuropathy (GAN)

C. Bruno, MD, E. Bertini, MD, A. Federico, MD, E. Tonoli, MS, M. L. Lispi, MD, D. Cassandrini, PhD, M. Pedemonte, MD, F. M. Santorelli, MD, M. Filocamo, PhD, M. T. Dotti, MD, A. Schenone, MD, A. Malandrini, MD and C. Minetti, MD

From the Neuromuscular Disease Unit (Drs. Bruno, Cassandrini, Pedemonte, and Minetti, and E. Tonoli) and Division of Pediatrics III (Dr. Filocamo), Department of Pediatrics, University of Genova, Giannina Gaslini Institute; Unit of Molecular Medicine (Drs. Bertini, Lispi, and Santorelli), Bambino Gesù Hospital, Rome; Institute of Neurological Sciences (Drs. Federico, Dotti, and Malandrini), University of Siena; Department of Neurological Sciences, Vision, and Genetics and Center for Biomedical Research (Dr. Schenone), University of Genova, Italy.

Address correspondence and reprint requests to Dr. C. Bruno, Neuromuscular Disease Unit, Department of Pediatrics, University of Genova, Istituto Giannina Gaslini, Largo G. Gaslini 5, I-16147 Genova, Italy; e-mail: claudiobruno{at}ospedale-gaslini.ge.it

Giant axonal neuropathy (GAN) is a rare autosomal recessive neurodegenerative disorder of early onset, clinically characterized by a progressive involvement of both peripheral and CNS. The diagnosis is based on the presence of characteristic giant axons, filled with neurofilaments, on nerve biopsy. Recently, the defective protein, gigaxonin, has been identified and different pathogenic mutations in the gigaxonin gene have been reported as the underlying genetic defect. Gigaxonin, a member of the BTB/kelch superfamily proteins, seems to play a crucial role in the cross talk between the intermediate filaments and the membrane network. The authors report clinical and molecular findings in five Italian patients with GAN. This study shows the allelic heterogeneity of GAN and expands the spectrum of mutations in the GAN gene. The frequent occurrence of private mutations stresses the importance of a complete gene analysis.

Received April 22, 2003. Accepted in final form August 13, 2003.




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
D. W. Cleveland, K. Yamanaka, and P. Bomont
Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway
Hum. Mol. Genet., April 15, 2009; 18(8): 1384 - 1394.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
H. Houlden, M. Groves, Z. Miedzybrodzka, H. Roper, T. Willis, J. Winer, G. Cole, and M. M Reilly
New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1267 - 1270.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
A. Alkan, A. Sigirci, R. Kutlu, S. Doganay, G. Erdem, and C. Yakinci
Giant Axonal Neuropathy: Diffusion-Weighted Imaging Features of the Brain
J Child Neurol, October 1, 2006; 21(10): 912 - 915.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
D. D. Zhang, S.-C. Lo, Z. Sun, G. M. Habib, M. W. Lieberman, and M. Hannink
Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway
J. Biol. Chem., August 26, 2005; 280(34): 30091 - 30099.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
E Demir, P Bomont, S Erdem, L Cavalier, M Demirci, G Kose, S Muftuoglu, A N Cakar, E Tan, S Aysun, et al.
Giant axonal neuropathy: clinical and genetic study in six cases
J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 825 - 832.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Li, D. Zhang, M. Hannink, and L. J. Beamer
Crystal Structure of the Kelch Domain of Human Keap1
J. Biol. Chem., December 24, 2004; 279(52): 54750 - 54758.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Hortnagel, N. Nardocci, G. Zorzi, B. Garavaglia, E. Botz, T. Meitinger, and T. Klopstock
Infantile neuroaxonal dystrophy and pantothenate kinase-associated neurodegeneration: Locus heterogeneity
Neurology, September 14, 2004; 63(5): 922 - 924.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.